Press release
Inhalable Drug Market Poised for Strong Growth, Expected to Reach Nearly US$ 47.21 Billion by 2029
25.08.2023 : Inhalable Drug Market Report Scope and Research MethodologyThe report offers a comprehensive analysis of the Inhalable Drug Market, utilizing rigorous research methodology, including data analysis and industry-validated insights. It encompasses market dynamics, trends, and profiles of key players. Competitive analysis, market segmentation, and regional growth patterns are also presented.
For detail insights on this market, request for methodology here @ https://www.maximizemarketresearch.com/market-report/inhalable-drug-market/123389/
What are Inhalable Drug Market Dynamics?
The rising incidence of respiratory ailments like COPD, asthma, and cystic fibrosis is a significant driver of market growth. In the US alone, asthma impacted more than 25 million individuals in 2017. The market is also being positively influenced by the increasing occurrence of non-respiratory disorders like diabetes and Parkinson's disease, particularly in the aging population.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary +
TOC]) @ https://www.maximizemarketresearch.com/request-sample/123389
What is Inhalable Drug Market Segmentation?
The Inhalable Drug Market's Product sector is dominated by the Dry Powder Formulations segment:
Dry powder formulations dominated the market for inhalable medications in 2022 because they were more effective and produced superior outcomes than other types. Additionally, the formulation has a strong pipeline and a wide product range, which contribute to its dominant market dominance. The shift in manufacturers' priorities toward developing products with microscopic particles is anticipated to fuel market growth over the course of the projected period. For instance, Cipla released Niveoli in April 2021, the country's first extra-fine particle inhaler. The inhaler's inclusion of hydrofluoroalkane (HFA) and beclomethasone-formoterol in patients with COPD and asthma ensures focused delivery to the small airways.
The category for respiratory diseases is projected to support the expansion of the market for inhalable drugs.
With a market share of 41.6% in 2022, the category for respiratory illnesses controlled the market's expansion. Inhalable drugs are frequently used to treat chronic respiratory illnesses like asthma, COPD, and bronchospasm as well as non-respiratory illnesses like diabetes and Parkinson's disease. Combination therapy of Inhaled Corticosteroid (ICS), Long-Acting Muscarinic Antagonist (LAMA), and Long-Acting 2 Adrenoceptor Agonist (LABA) is widely used for the treatment of COPD and asthma due to its effectiveness, capacity to reduce pulmonary inflammation, and reduced need for hospitalization.
Because of this, numerous pharmaceutical firms have created combination medications. For instance, the US Food and Drug Administration approved the combination drug Trelegy Ellipta in September 2017.
1 Global Inhalable Drug Market, by Product (2022-2029)
• Aerosol
• Dry Powder Formulation
• Spray
2 Global Inhalable Drug Market, by Application (2022-2029)
• Respiratory Diseases
• Non-Respiratory Disease
3 Global Inhalable Drug Market, by Distribution Channel (2022-2029)
• Hospital Pharmacy
• Pharmacy Stores
• Other
For any Queries Linked with the Report, Ask an Analyst@ https://www.maximizemarketresearch.com/inquiry-before-buying/123389
Who are Inhalable Drug Market Key Players?
1. Teva Pharmaceutical Industries Ltd
2. Cipla Inc
3. Amneal Pharmaceuticals Inc
4. Glenmark Pharmaceuticals Inc
5. AstraZeneca
6. Vectura
7. Sanofi
8. Mylan
9. Mundipharma
10. GlaxoSmithKline
11. Boehringer Ingelheim International GmbH
12. Sunovion Pharmaceuticals, Inc.
13. Philips Healthcare
14. CareFusion Corporation
15. Roche Diagnostics
16. Regeneron
17. Genentech, Inc.
18. Sumitomo Dainippon
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report @ https://www.maximizemarketresearch.com/request-customization/123389
Regional Insights:
North America takes the lead in the inhalable drug market, with active government initiatives, awareness campaigns, and a growing focus on COPD treatment alternatives. The Asia Pacific region is expected to experience the fastest growth due to improved healthcare infrastructure, increasing patient awareness, and rising disposable income. Furthermore, medical tourism and market entries by global players are contributing to the growth potential in this region.
Key Offerings:
Past Market Size and Competitive Landscape (2017 to 2022)
Past Pricing and price curve by region (2017 to 2022)
Industrial Manipulator Market Size, Share, Size Forecast by different segment | 2023-2029
Industrial Manipulator Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Industrial Manipulator Market Segmentation - A detailed analysis by Type, Application and Region
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Please connect with our representative, who will ensure you to get a report sample here @ https://www.maximizemarketresearch.com/request-sample/123389
Related Reports:
Global Legal AI Software Market https://www.maximizemarketresearch.com/market-report/global-legal-ai-software-market/30850/
Global Big Data and Data Engineering Services Market https://www.maximizemarketresearch.com/market-report/big-data-and-data-engineering-services-market/14625/
Global Automotive VVT System Market https://www.maximizemarketresearch.com/market-report/global-automotive-vvt-system-market/39494/
Global Amniotic Products Market https://www.maximizemarketresearch.com/market-report/global-amniotic-products-market/116700/
Global Fall Detection System Market https://www.maximizemarketresearch.com/market-report/global-fall-detection-system-market/25573/
Global Recommendation Engine Market https://www.maximizemarketresearch.com/market-report/recommendation-engine-market/2852/
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
444 West Lake Street, Floor 17, Chicago, IL, 60606, USA.
+1 800 507 4489 +91 9607365656
sales@maximizemarketresearch.com
https://www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inhalable Drug Market Poised for Strong Growth, Expected to Reach Nearly US$ 47.21 Billion by 2029 here
News-ID: 3180985 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
The Courier Services Market size was valued at USD 453.56 Billion in 2024 and the total Courier Services revenue is expected to grow at a CAGR of 5.8% from 2025 to 2032, reaching nearly USD 712.07 Billion.
Courier Services Market Overview
The global Courier Services Market has experienced significant growth, driven by the rising adoption of e-commerce, growing Internet penetration, and changing consumer lifestyles. Courier services provide quick, door-to-door delivery solutions for…

WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market was valued at USD 6.47 Billion in 2023, and it is expected to reach USD 17.83 Billion by 2030, exhibiting a CAGR of 15.58% during the forecast period (2024-2030).
WealthTech Solutions Market Overview
The global WealthTech Solutions Market is undergoing a transformative phase, driven by changing customer preferences, digital innovation, and evolving financial landscapes. WealthTech solutions provide digital tools and platforms that enhance operational efficiency for financial advisors, wealth…

Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR G …
Global Rapid Test Market size was valued at USD 40.75 Bn. in 2024 and the total Rapid Test Market is expected to grow by 8.81% from 2025 to 2032, reaching nearly USD 80.07 Bn.
Rapid Test Market Overview
The global Rapid Test Market is witnessing significant growth, driven by the increasing demand for fast, accessible diagnostic solutions across healthcare settings and home-care applications. Rapid tests are designed to detect the presence of…

Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAG …
Global Agarwood Oil Market size is expected to reach nearly US$ 496.84 Mn by 2032 with the CAGR of 5.42% during the forecast period.
Agarwood Oil Market Overview
Agarwood Oil, derived from the resinous wood of Aquilaria trees primarily found in Southeast Asia, is highly valued for its aromatic and therapeutic properties. Formed when the wood is infected by yeast, pests, or microbes, the oil possesses antimicrobial, antioxidant, anti-inflammatory making it widely…
More Releases for Inhalable
Major Growth Driver Identified in 2025 Inhalable Drugs Market: Surge In Respirat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Inhalable Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for inhalable medications has been expanding robustly over the past few years. Its size is projected to rise from $35.06 billion in 2024 to $36.91 billion in 2025, indicating a compound annual growth…
Inhalable Biologics Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Health Coaching Market - By Type (Peptides And Proteins, Vaccines, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Respiratory Diseases, Diabetes, Cancer), Dosage Form (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), Trends, Industry Competition Analysis, Revenue And Forecast To 2034."
The global inhalable biologics market is estimated to…
Major Growth Driver Identified in 2025 Inhalable Drugs Market: Surge In Respirat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Inhalable Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for inhalable medications has seen considerable expansion in the past few years. The market worth, projected to jump from $35.06 billion in 2024 to $37.27 billion in 2025, reflects a compound annual growth…
Inhalable Drugs: Transforming Respiratory Healthcare Delivery
The Business Research Company recently released a comprehensive report on the Global Inhalable Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Inhalable Drugs Market Size, Outlook, Overview 2024-2033
The inhalable drugs market size has grown strongly in recent years. It will grow from $33.29 billion in 2023 to $35.48 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased geriatric population, patient preference for non-invasive treatments, increased focus on respiratory health, emerging markets growth.
The inhalable drugs market size is expected to see strong…
Global Inhalable Drugs Market Size - Forecasts to 2026
As per the research conducted by GME, the Global Inhalable Drugs Market will grow with a CAGR value of 6.8% by 2026. The increasing number of tobacco consumption in the form of smoking among people leads to chronic and acute bronchitis, other pulmonary disorders. Awareness by various governments and campaigns conducted for the treatment of a greater number of people who can’t afford the treatment of lung diseases.
Browse 151 Market…